21 CFR Part 880 · General Hospital and Personal Use Devices

21 CFR 880.6430

Liquid medication dispenser

21 CFR 880.6430 is the regulation titled “Liquid medication dispenser” in 21 CFR Part 880, General Hospital and Personal Use Devices. Since 2021, 1 FDA warning letter has cited it.

Letters citing it
1 since 2021
Jan 1 to Oct 30, 2026
1 against 0 on the same dates in 2025
Most often cited with
21 CFR 880.9, in 1 letter
Closed out
0% of these letters have a published close-out
See the letter citing 21 CFR 880.6430 →

Letters citing it, by year issued

It is a biologics letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 02022
  3. 02023
  4. 02024
  5. 02025
  6. 12026

What FDA writes when it cites it

The finding headings that cite 21 CFR 880.6430 most often, as written in the letters.

  • 1 letterBecause there is evidence that APLICOR 3D is intended for uses that are different from those of legally marketed devices classified under 21 CFR 880.6430, it exceeds the limitations described in 21 CFR 880.9 and is not…

The regulation

Read the text of 21 CFR 880.6430 (eCFR, as of Sep 1, 2026)

(a) Identification. A Liquid medication dispenser is a device intended for medical purposes that is used to issue a measured amount of liquid medication.

(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 880.9. The device is also exempt from the current good manufacturing practice requirements of the quality management system regulation in part 820 of this chapter, except for requirements concerning records and complaint files under § 820.35 of this chapter.

[45 FR 69682, Oct. 21, 1980, as amended at 66 FR 38806, July 25, 2001; 90 FR 55988, Dec. 4, 2025]

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 880.6430.

Latest letters citing it

The letter citing 21 CFR 880.6430 that FDA posted most recently.

See the letter citing 21 CFR 880.6430 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.